Cyanide and carbon monoxide toxicity in smoke inhalation

Overview

Cyanide and carbon monoxide are the reason a fire victim can be pulled from a closed-space fire with minimal cutaneous burns and still die. Most fatalities from fires are not due to burns but result from inhalation of toxic gases produced during combustion ^[10]. Carbon monoxide and cyanide are the two deadliest of those gases, and the literature has long held that there are far deadlier things lurking within smoke than just heat and particulate matter ^[11]. Carbon monoxide remains the predominant cause of death among fire victims, and victims of smoke inhalation may carry significant cyanide poisoning alongside it [20, 21]. The importance of cyanide as a component of inhalational injury in burn patients is increasingly recognized, and prompt recognition and management is described as vital for optimizing burn survival ^[19].

This page is about the systemic poisoning, not the airway. Inhalation injury is classically divided into supraglottic, subglottic, and systemic components; carbon monoxide and cyanide are the systemic-toxicity arm ^[22]. The defining clinical problem is that both poisons produce severe tissue hypoxia without dramatic vital-sign changes ^[12], so recognition depends on history and a high index of suspicion rather than on any single confirmatory test. Carboxyhemoglobin is easy to measure and long-lasting; cyanide is the opposite, with a short blood half-life and poor stability, which is why its toxidrome has historically been overlooked in fire victims ^[23]. The combination is treacherous: animal data show combined CO and cyanide poisoning is more lethal than either alone and at lower concentrations ^[2]. Airway management, ventilation strategy, and the pulmonary pathophysiology of inhalation injury are covered on adjacent pages; this page stays on the two metabolic poisons and how they are recognized and treated.

Epidemiology

Carbon monoxide is the single most lethal exposure in fire smoke. It is the predominant cause of death among fire victims, and across inhalation injury more broadly it has become one of the most frequent causes of death in burn patients [20, 24]. Inhalation injury itself is common: it occurs in roughly one-third of all major burns and affects nearly one-third of major burn victims [24, 25]. Beyond fires, carbon monoxide is one of the most common causes of poisoning in both industry and homes, and an estimated 50,000 people visit US emergency departments for CO poisoning each year [26, 27]. In one US series, structure fires numbered over 357,500 annually with 2,710 civilian deaths ^[28].

Cyanide is rarer and harder to pin down, but real. Smoke inhalation is the most common cause of acute cyanide poisoning in the developed world, and cyanide toxicity is described as common after significant smoke inhalation [29, 30]. The numbers from forensic series temper that framing. In a study of fire fatalities, carboxyhemoglobin averaged 44.9% across 433 deaths and exceeded the conventional fatal threshold in 195, while cyanide averaged only 1.0 mg/L and exceeded its fatal threshold in just 31 of 364 cases ^[18]. Where cyanide was elevated above 3 mg/L, the mean carboxyhemoglobin was 62.5%, so the two poisons travel together ^[18]. A recent cohort found that of 172 patients, 26.2% had CO poisoning and 8.1% met criteria for presumptive cyanide poisoning, all of whom also had CO intoxication ^[31]. The synthetic-materials trend matters here: modern plastics, papers, and textiles release far higher concentrations of hydrogen cyanide when heated, so cyanide's contribution to fire deaths is described as an increasing public-health concern [12, 32].

Certain populations carry disproportionate risk. Fires remain a major killer of children, accounting for as much as 34% of fatal injuries in those younger than 16 ^[33]. For people over 65, the risk of dying in a residential fire is doubled relative to the general population ^[34]. Motor-vehicle and enclosed-space settings concentrate exposure; in one autopsy series the highest carbon monoxide levels were seen in victims found in motor vehicles ^[35].

Pathophysiology

The two poisons share an end point of cellular hypoxia but reach it by different routes. Carbon monoxide has a high affinity for hemoglobin, forming carboxyhemoglobin and producing a decrease in both oxygen-carrying capacity and oxygen release that leads to end-organ hypoxia ^[36]. Carbon monoxide simply binds hemoglobin and reduces oxygen delivery ^[1]. Cyanide works one step downstream: when it enters the body by inhalation it binds cytochrome oxidase in the mitochondria, blocking the cell from using oxygen at all ^[12]. Its primary target is mitochondrial cytochrome oxidase ^[37]. With aerobic metabolism shut off, cells shift to anaerobic metabolism, generating lactic acid and the metabolic acidosis that is the biochemical hallmark of cyanide poisoning [12, 5]. The consequence that matters clinically is that these gases cause severe tissue hypoxia without significant vital-sign changes ^[12].

The synergy between the two is the dangerous part. Cyanide intoxication is frequently a comorbid disease with CO in enclosed-fire inhalation injury and acts synergistically with CO to effectively lower the lethal doses of both ^[1]. Animal studies show combined CO and cyanide poisoning is more lethal than either alone and at lower concentrations ^[2]. Other combustion gases compound the picture: smoke contains carbon monoxide, hydrogen cyanide, nitrogen oxides, and other irritants, and major oxygen depletion below 10% substantially reduces the time to death when added to lethal or sublethal CO or cyanide [25, 38]. Even relatively low levels of methemoglobinemia can complicate concomitant CO poisoning through additive effects on oxygen binding and delivery ^[39]. Modern fires generate appreciable blood cyanide; hydrogen cyanide is likely present in measurable amounts in the blood of fire victims, and its addition can produce lower-than-expected carboxyhemoglobin levels in fire deaths ^[38]. Forensic detection of cyanide in fire victims confirms the exposure: cyanide was detected in the cardiac blood of 76.3% of cases in one postmortem series ^[40].

There is also a neurologic dimension that extends beyond the acute hypoxic insult. In rat models, acute inhalation of combustion smoke disrupts nitric oxide homeostasis in the brain, and elevated protein nitration with reduced hippocampal mitochondrial respiration persists beyond the time needed to restore normal blood oxygen and carboxyhemoglobin levels ^[41]. That persistence of mitochondrial dysfunction after the blood markers normalize is part of why carbon monoxide produces delayed neurologic injury.

Assessment

Diagnosis rests on history and clinical suspicion, because the confirmatory tests are either slow or nonexistent. Cyanide poisoning is still considered an overlooked diagnosis in fire victims, and the difficulty is structural: there is no point-of-care cyanide test at the scene of a fire, so first responders and clinicians base treatment decisions on patient history, clinical signs, and indirect data that have not been proven to correspond with actual systemic cyanide levels [42, 4]. Cyanide's short blood half-life and poor stability have hampered recognition of its toxidrome, while carboxyhemoglobin, as a marker of CO poisoning, is easily measured and long-lasting ^[23]. One review framed the practical reality bluntly: most diagnoses are made on clinical grounds and most therapy is supportive ^[43].

For carbon monoxide, carboxyhemoglobin is the workhorse marker. It is regarded as a reliable marker characterizing both the severity of injury and the efficacy of treatment in CO poisoning, and the diagnosis is confirmed by documenting an elevated level [44, 36]. Venous and arterial levels are similar, which simplifies sampling, though venous carboxyhemoglobin can underestimate arterial content [33, 44]. A central caveat survives all of this: absolute indications for hyperbaric oxygen do not exist because there is a low correlation between carboxyhemoglobin levels and the severity of the clinical state ^[6]. Symptoms grade with exposure rather than tracking the number cleanly. Mild-to-moderate CO poisoning brings headache, dizziness, fatigue, nausea, vomiting, general malaise, and altered mental status; more severe cases bring tachycardia, tachypnea, and central nervous system depression [36, 27]. A falsely normal pulse oximeter reading is a recognized trap, since standard oximetry can read normal in the face of carboxyhemoglobin ^[14].

For cyanide the surrogate is lactate. Metabolic acidosis with significant lactic acidosis is the laboratory finding consistently associated with cyanide toxicity, and elevated plasma lactate with cardiovascular collapse should suggest cyanide intoxication [9, 45]. One frequently cited threshold holds that a plasma lactate of 10 mmol/L or higher in fire victims without severe burns, and 8 mmol/L or higher in pure cyanide poisoning, is a sensitive and specific indicator of cyanide intoxication ^[5]. Clinical features of cyanide poisoning include coma, respiratory arrest, and cardiovascular collapse, with dyspnea, altered mental status, seizures, and lactic acidosis among common signs [5, 37]. The classic teaching signs are unreliable: contrary to general reviews, reports of cherry-red skin and bitter-almond odor were rare among published cyanide cases, and providers may overlook cyanide when those expected features are absent ^[9]. In one case series, most patients were unresponsive (78%), hypotensive (54%), or in respiratory failure (73%), with cherry-red skin in only 11% and a detectable odor in 15% ^[9]. Loss of consciousness is a good sign of systemic toxicity, but the respective roles of CO, cyanide, and other gases cannot be separated clinically ^[13].

Because real-time cyanide measurement is unavailable, attention has turned to surrogate and forensic markers. The minor cyanide metabolite 2-aminothiazoline-4-carboxylic acid (ATCA) has been proposed as a stable forensic marker of exposure, with significantly higher concentrations in fire victims than non-fire victims [46, 47]. The practical message for the clinician remains that cyanide diagnosis is very difficult, and failure to recognize it may lead to inadequate or inappropriate treatment ^[48].

Management

Oxygen is the foundation for both poisons. Oxygen administration is described as the cornerstone supportive therapy, and oxygen counteracts cyanide action efficiently at the mitochondrial level [13, 5]. Several reviews state that any patient suspected of inhalation injury should receive high-concentration supplemental oxygen to reverse hypoxia and displace carbon monoxide from protein binding sites, and that immediate oxygen therapy should not be delayed pending diagnostic tests or because of a normal-appearing oxygen saturation [6, 14]. For carbon monoxide, 100% normobaric oxygen is described as the standard of care, decreasing the half-life of CO in the blood from about 5 hours to 1 hour ^[1]. In a cohort of CO-poisoned patients treated with 100% oxygen at atmospheric pressure, the measured carboxyhemoglobin half-life was 74 minutes ^[49].

Hyperbaric oxygen is the contested escalation. It hastens carboxyhemoglobin elimination and favorably modulates the inflammatory processes of CO poisoning, an effect not seen with normobaric oxygen, and reduces the half-life of CO to roughly 20 minutes [27, 1]. On the strength of three supportive randomized trials in humans plus considerable animal evidence, one consensus source states hyperbaric oxygen should be considered for all cases of acute symptomatic CO poisoning, and that it is indicated for CO poisoning complicated by cyanide poisoning [27, 50]. Mechanistically, hyperbaric oxygen improves mitochondrial function, transiently inhibits lipid peroxidation, impairs leukocyte adhesion to injured microvasculature, and reduces the brain inflammation driven by CO-induced myelin basic protein adduct formation ^[27]. The countervailing evidence is real and is addressed in the controversies section.

For cyanide, hydroxocobalamin has become the antidote of choice in this setting. It is described as the gold-standard treatment for cyanide toxicity, binding cyanide to form non-toxic cyanocobalamin that is cleared renally, and it is recommended by the American Heart Association for suspected hydrogen cyanide poisoning [51, 52]. Hydroxocobalamin is favored over the older methemoglobin-inducing antidotes precisely because it neutralizes cyanide without interfering with cellular oxygen use and does not further reduce oxygen-carrying capacity, which matters when carboxyhemoglobin is already present [15, 53]. One review characterized it as having many of the features of the ideal cyanide antidote: rapid onset, tolerability and safety conducive to prehospital use, safety in smoke-inhalation victims, and no harm when given to non-poisoned patients ^[15]. Several sources describe hydroxocobalamin as appropriate for empiric out-of-hospital treatment of presumptive cyanide poisoning, and a prehospital French series reported it suitable for that use [54, 55]. The older methemoglobin-forming agents are potent but impair oxygen delivery by converting hemoglobin to methemoglobin, and experimental data showed increased mortality in CO- and cyanide-poisoned rats treated with them, which limits their role when CO coexists ^[5]. Sodium thiosulfate enhances metabolic elimination of cyanide but acts with delay; one source pairs continuous sodium thiosulfate with hydroxocobalamin in massive poisoning [53, 5]. The Lilly Cyanide Antidote Kit available in America carries its own inherent toxicity ^[21].

Because no rapid test exists, empiric treatment criteria have emerged. One protocol gives hydroxocobalamin to patients exposed to smoke in an enclosed space within 2 hours who experienced cardiac arrest at the scene, had a Glasgow Coma Score below 10, or had a lactate above 10 and carboxyhemoglobin above 10 ^[28]. A separate appropriate-use-criteria approach was reported to identify severely ill smoke-inhalation victims and guide hydroxocobalamin treatment ^[56]. Practice is far from uniform: a survey found the majority of burn centers (59%) do not test for cyanide on admission and do not administer an antidote on clinical suspicion alone, with opinions on instant administration split ^[57]. Carbon monoxide poisoning is more regularly assessed than cyanide at the point of burn care because it is easier to measure and simpler to treat ^[58].

Complications

The complications fall into two groups: the delayed injury of the poisoning itself, and the adverse effects of treatment. Carbon monoxide is notorious for delayed neurologic sequelae. Individuals poisoned by CO often develop brain injury manifesting as cognitive sequelae, anxiety and depression, persistent headaches, dizziness, sleep problems, motor weakness, vestibular and balance problems, peripheral neuropathies, hearing loss, tinnitus, and a Parkinsonian-like syndrome [27, 50]. One source states that all patients with CO poisoning should be informed about the risk of delayed neurologic sequelae ^[59]. CO poisoning has also been reported to cause blindness, rhabdomyolysis with acute kidney injury, and exercise-induced myocardial ischemia in low-cardiovascular-risk patients [60, 61, 62]. Cyanide can likewise produce myocardial infarction and other cardiac complications ^[63]. Both poisons can be complicated by methemoglobinemia, which is largely unrecognized after fire exposure and which can worsen oxygen delivery in a patient already burdened by carboxyhemoglobin ^[39].

The antidote carries its own profile. The expected and benign adverse events of hydroxocobalamin are chromaturia and skin discoloration: a characteristic dark-red to purple urine that can mimic hematuria and resolves spontaneously, and a pink or red skin discoloration [64, 16]. The more consequential signal is renal. Retrospective studies have associated hydroxocobalamin with acute kidney injury, and case reports describe crystalline nephropathy and interference with renal replacement therapy [56, 17]. In one burn-center series, 22 of 35 patients (63%) who received hydroxocobalamin developed acute kidney injury within the first 72 hours, and 60% required continuous renal replacement therapy at some point ^[17]. Another retrospective analysis found hydroxocobalamin associated with an increased risk of AKI and severe AKI, though not with survival, after smoke inhalation ^[65]. The picture is not uniform: a study specifically examining mesenteric ischemia found none of its hydroxocobalamin-treated patients developed mesenteric ischemia or necrotic bowel, concluding the drug does not increase that risk ^[66]. Hydroxocobalamin also interferes with laboratory assays, affecting 27 of 77 analytes in one study, with chemistry and coagulation tests most affected ^[67]. The methemoglobinemia signal recurs with hydroxocobalamin in case reports, where methemoglobin rose and peaked many hours after administration, a consideration for emergency physicians when a treated patient fails to improve [68, 69].

Special Considerations

Several populations and exposure settings change the calculus. In pregnancy, fetal hemoglobin binds CO 2.5- to 3-fold more strongly than maternal hemoglobin, exacerbating the effect in the burned pregnant patient, and these toxins concentrate at higher levels in the fetus than the mother [1, 2]. The Food and Drug Administration approved hydroxocobalamin for use in pregnant patients in the acute setting when cyanide toxicity is suspected ^[2]. In children, the sources and manifestations of acute cyanide poisoning are qualitatively similar to adults, but children may be more vulnerable to poisoning from some sources, and methemoglobinemia from nitrite-based antidotes may be excessive at standard adult dosing, which makes hydroxocobalamin an attractive pediatric alternative ^[70]. Hydrogen cyanide has been flagged as a major concern in children, where rapid hydroxocobalamin administration may be critical ^[71].

Pre-existing disease and age shift vulnerability and complicate forensic interpretation. Cardiovascular disease, particularly atherosclerotic heart disease, increases vulnerability to carbon monoxide and probably other asphyxiant gases ^[34]. Both atherosclerotic and hypertensive cardiovascular disease, and increasing age, were associated with statistically significantly lower carboxyhemoglobin levels at death, meaning a vulnerable patient may die at a lower measured level ^[72]. Sickle cell disease has been hypothesized to confer a protective effect in CO poisoning in a single remarkable case of complete neurologic survival ^[73]. Firefighters carry occupational risk: median personal air concentrations during fire attack and search frequently exceed short-term exposure limits, underscoring the importance of self-contained breathing apparatus during overhaul and ventilation activities ^[74].

The forensic setting deserves its own note because much of the cyanide literature is autopsy-based. Soot in the respiratory tract and cherry-red coloration of a recovered body both correlate with elevated carboxyhemoglobin ^[75]. But carboxyhemoglobin and airway findings alone are insufficient in fire-related deaths, and trauma-positive cases show lower carboxyhemoglobin and fewer airway findings, so a low level does not exclude a fire death ^[76]. Smoke obscuration is a poor indicator of the carbon monoxide danger, an important caveat for anyone attempting rescue ^[77].

Outcomes

Outcome tracks the severity of the systemic insult and the speed of intervention. Carbon monoxide poisoning is the most common cause of death in inhalation injury, and deaths from smoke inhalation most often occur because the victim cannot escape the toxic effects of carbon monoxide [24, 78]. When chemical airway injury and these systemic poisons compound a cutaneous burn the mortality is exceedingly high; one early series cited 48% to 86% when the injury accompanied serious cutaneous burns, and inhalation injury carries an attributable excess mortality that worsens the prognosis of burned patients [79, 80]. In a large cyanide-exposure series, clinical features associated with fatal outcome were cardiac arrest, hypotension, coma, and lactic acidosis, and smoke inhalation caused the majority of severe and fatal cases ^[81]. Death can come fast: it may occur within seconds of acute inhalation of high concentrations of hydrogen cyanide, and many fire fatalities die at the scene [82, 83].

The antidote outcome data are observational but consistent in direction. In a series of ICU patients given hydroxocobalamin, 72% survived, and among those later confirmed to have had cyanide poisoning 67% survived ^[16]. A pooled review of 482 patients with known survival status found 66% survived to hospital discharge ^[52]. A comparative burn-center study found that while mortality was similar with and without hydroxocobalamin (29% vs 28%), the treated group had a lower pneumonia rate (23% vs 49%), fewer ventilator days, more ventilator-free days, and shorter ICU stay ^[84]. Hydroxocobalamin use was also reported to reduce healthcare resource utilization and per-patient costs, largely through shorter length of stay ^[4]. Cases that resulted in death had significantly longer times to hydroxocobalamin administration in one cohort, reinforcing that speed matters ^[85]. These are encouraging signals, but the evidence remains observational and heterogeneous, and two reviews found similar mortality between hydroxocobalamin and supportive-treatment groups [52, 7]. A full recovery from life-threatening cyanide poisoning is possible ^[23].

Controversies and Evidence Gaps

• Whether cyanide is a major driver of fire deaths is unproven. It is assumed that cyanide poisoning is a major component of smoke inhalation injury, but one forensic review found scientific verification of that assumption lacking, and concluded specific cyanide assay and treatment are rarely necessary in fire victims given that detoxification can occur with aggressive supportive care alone ^[18].
• The cyanide-antidote evidence base is thin. The evidence for cyanide antidotes is limited by a lack of randomized controlled trials in humans, and there are no clear guidelines on the antidote of choice [19, 86]. Empiric hydroxocobalamin in suspected-but-unconfirmed smoke-inhalation cyanide toxicity remains explicitly described as controversial, and one source notes that 60% of patients treated with hydroxocobalamin had none of the six clinical indicators for potential cyanide toxicity [7, 87]. Evidence that hydroxocobalamin is effective for inhaled hydrogen cyanide alone is described as lacking, with efficacy extrapolated from ingested cyanide salts ^[88].
• Hyperbaric oxygen for CO is genuinely contested. Evidence on the benefit of hyperbaric oxygen is described as scant and controversial owing to study heterogeneity, current findings are conflicting, and one review found insufficient evidence to support or disprove its routine use in burn care; another study saw no effect on survival [59, 89, 90, 91]. This sits in tension with the consensus sources that recommend considering hyperbaric oxygen for all symptomatic CO poisoning ^[27].
• The classic lethal thresholds may be arbitrary. No evidence supports the assumption of fixed lethal thresholds of 50% for carboxyhemoglobin and 3 mg/L for cyanide in fire victims, and traditionally quoted combustion-product levels are too high to account for all the incapacitation and death seen in fires [23, 92].
• Diagnosis lacks a rapid test and a consensus. No consensus exists for diagnosis or grading of inhalation injury, and management of CO and cyanide exposure in smoke inhalation remains controversial, with large variation in treatment worldwide [22, 6]. Hydrogen cyanide intoxication is often underdiagnosed; only 42.9% of cases were correctly identified in the emergency department in one cohort ^[31].
• No mass-casualty antidote exists. Despite the risk to large numbers in a single event, an antidote capable of administration at the scale needed for a mass-casualty, prehospital scenario does not yet exist ^[93].

References

[1] Culnan DM, et al.. "Carbon Monoxide and Cyanide Poisoning in the Burned Pregnant Patient: An Indication for Hyperbaric Oxygen Therapy." Annals of plastic surgery 2018. PMID: 29461288 https://pubmed.ncbi.nlm.nih.gov/29461288/ [2] Roderique EJ, Gebre-Giorgis AA, Stewart DH, Feldman MJ, Pozez AL. "Smoke inhalation injury in a pregnant patient: a literature review of the evidence and current best practices in the setting of a classic case." Journal of burn care & research : official publication of the American Burn Association 2012. PMID: 22293595 https://pubmed.ncbi.nlm.nih.gov/22293595/ [3] Gigengack RK, Cleffken BI, Loer SA. "Advances in airway management and mechanical ventilation in inhalation injury." Current opinion in anaesthesiology 2020. PMID: 33060384 https://pubmed.ncbi.nlm.nih.gov/33060384/ [4] Sanders KN, et al.. "Cost impact of hydroxocobalamin in the treatment of patients with known or suspected cyanide poisoning due to smoke inhalation from closed-space fires." Burns : journal of the International Society for Burn Injuries 2021. PMID: 34903402 https://pubmed.ncbi.nlm.nih.gov/34903402/ [5] Mégarbane B, Delahaye A, Goldgran-Tolédano D, Baud FJ. "Antidotal treatment of cyanide poisoning." Journal of the Chinese Medical Association : JCMA 2003. PMID: 12854870 https://pubmed.ncbi.nlm.nih.gov/12854870/ [6] Tanizaki S. "Assessing inhalation injury in the emergency room." Open access emergency medicine : OAEM 2015. PMID: 27147888 https://pubmed.ncbi.nlm.nih.gov/27147888/ [7] Jin WY, Huang DC, Guo J, Jin D, Ying AF. "Evidence for Hydroxocobalamin in Cyanide Toxicity Caused by Smoke Inhalation: An Updated Systematic Review." Emergency medicine international 2025. PMID: 41497958 https://pubmed.ncbi.nlm.nih.gov/41497958/ [8] Weaver LK. "Carbon Monoxide Poisoning (Reprinted from the 2023 Hyperbaric Indications Manual 15th edition)." Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2024. PMID: 39348519 https://pubmed.ncbi.nlm.nih.gov/39348519/ [9] Parker-Cote JL, Rizer J, Vakkalanka JP, Rege SV, Holstege CP. "Challenges in the diagnosis of acute cyanide poisoning." Clinical toxicology (Philadelphia, Pa.) 2018. PMID: 29417853 https://pubmed.ncbi.nlm.nih.gov/29417853/ [10] Maybauer DM, Traber DL, Radermacher P, Herndon DN, Maybauer MO. "[Treatment strategies for acute smoke inhalation injury]." Der Anaesthesist 2006. PMID: 16826418 https://pubmed.ncbi.nlm.nih.gov/16826418/ [11] Huzar TF, George T, Cross JM. "Carbon monoxide and cyanide toxicity: etiology, pathophysiology and treatment in inhalation injury." Expert review of respiratory medicine 2013. PMID: 23547992 https://pubmed.ncbi.nlm.nih.gov/23547992/ [12] Doman G, Aoun J, Truscinski J, Truscinski M, Aouthmany S. "Cyanide Poisoning." Journal of education & teaching in emergency medicine 2022. PMID: 37465777 https://pubmed.ncbi.nlm.nih.gov/37465777/ [13] Hantson P, Benaissa L, Baud F. "[Smoke poisoning]." Presse medicale (Paris, France : 1983) 1999. PMID: 10598158 https://pubmed.ncbi.nlm.nih.gov/10598158/ [14] Vigh Z, Johnson P, Thomovsky EJ, Brooks AC. "Smoke Inhalation in Veterinary Patients: Pathophysiology, Diagnosis, and Management." Journal of the American Animal Hospital Association 2024. PMID: 39235782 https://pubmed.ncbi.nlm.nih.gov/39235782/ [15] Hall AH, Saiers J, Baud F. "Which cyanide antidote?" Critical reviews in toxicology 2009. PMID: 19650716 https://pubmed.ncbi.nlm.nih.gov/19650716/ [16] Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. "Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation." Annals of emergency medicine 2007. PMID: 17481777 https://pubmed.ncbi.nlm.nih.gov/17481777/ [17] Pruskowski KA, Britton GW, Cancio LC. "Outcomes after the administration of hydroxocobalamin." International journal of burns and trauma 2020. PMID: 33224611 https://pubmed.ncbi.nlm.nih.gov/33224611/ [18] Barillo DJ, Goode R, Esch V. "Cyanide poisoning in victims of fire: analysis of 364 cases and review of the literature." The Journal of burn care & rehabilitation 1994. PMID: 8150843 https://pubmed.ncbi.nlm.nih.gov/8150843/ [19] MacLennan L, Moiemen N. "Management of cyanide toxicity in patients with burns." Burns : journal of the International Society for Burn Injuries 2014. PMID: 24994676 https://pubmed.ncbi.nlm.nih.gov/24994676/ [20] Lee AS, Mellins RB. "Lung injury from smoke inhalation." Paediatric respiratory reviews 2006. PMID: 16765298 https://pubmed.ncbi.nlm.nih.gov/16765298/ [21] Hall AH, Rumack BH. "Hydroxycobalamin/sodium thiosulfate as a cyanide antidote." The Journal of emergency medicine 1987. PMID: 3295013 https://pubmed.ncbi.nlm.nih.gov/3295013/ [22] Foncerrada G, et al.. "Inhalation Injury in the Burned Patient." Annals of plastic surgery 2018. PMID: 29461292 https://pubmed.ncbi.nlm.nih.gov/29461292/ [23] Baud FJ. "Cyanide: critical issues in diagnosis and treatment." Human & experimental toxicology 2007. PMID: 17439922 https://pubmed.ncbi.nlm.nih.gov/17439922/ [24] Heimbach DM, Waeckerle JF. "Inhalation injuries." Annals of emergency medicine 1988. PMID: 3057948 https://pubmed.ncbi.nlm.nih.gov/3057948/ [25] Lee-Chiong TL, Matthay RA. "Burns and smoke inhalation." Current opinion in pulmonary medicine 1995. PMID: 15786598 https://pubmed.ncbi.nlm.nih.gov/15786598/ [26] Gobbato F, Cont A. "[Acute carbon monoxide poisoning]." Giornale italiano di medicina del lavoro 1989. PMID: 2519740 https://pubmed.ncbi.nlm.nih.gov/2519740/ [27] Weaver LK. "Hyperbaric oxygen therapy for carbon monoxide poisoning." Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2014. PMID: 25109087 https://pubmed.ncbi.nlm.nih.gov/25109087/ [28] Snodgrass K, Coffey R, Mandell SP, Faris J. "Impact of Protocol Development on Hydroxocobalamin Use for Smoke Inhalation Injury with Suspected Cyanide Toxicity: A Pre-Post Analysis." Journal of burn care & research : official publication of the American Burn Association 2026. PMID: 42011936 https://pubmed.ncbi.nlm.nih.gov/42011936/ [29] Mastenbrook J, Zamihovsky R, Brunken N, Olsen T. "Intraosseous administration of hydroxocobalamin after enclosed structure fire cardiac arrest." BMJ case reports 2021. PMID: 33692053 https://pubmed.ncbi.nlm.nih.gov/33692053/ [30] Hamad E, Babu K, Bebarta VS. "Case Files of the University of Massachusetts Toxicology Fellowship: Does This Smoke Inhalation Victim Require Treatment with Cyanide Antidote?" Journal of medical toxicology : official journal of the American College of Medical Toxicology 2016. PMID: 26831054 https://pubmed.ncbi.nlm.nih.gov/26831054/ [31] Lobo-Antuña V, Lobo-Antuña M, Fernández-Soro A, Rubini-Puig R, Tamarit-García JJ, Climent-Diaz B. "Smoke-inhalation victims in a tertiary ED: prevalence of presumed hydrogen-cyanide co-poisoning and clinical correlates." Internal and emergency medicine 2026. PMID: 41530611 https://pubmed.ncbi.nlm.nih.gov/41530611/ [32] Hancock LA, Eiriksdottir B, Suman SG. "Pharmacokinetics and Efficacy of a Cyanide-Neutralizing [Mo2O2(µ-S)2]2+ Based Metallodrug in NMRI Mice." Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2026. PMID: 42183871 https://pubmed.ncbi.nlm.nih.gov/42183871/ [33] Walker AR. "Emergency department management of house fire burns and carbon monoxide poisoning in children." Current opinion in pediatrics 1996. PMID: 8814401 https://pubmed.ncbi.nlm.nih.gov/8814401/ [34] Eggert E, Huss F. "Medical and biological factors affecting mortality in elderly residential fire victims: a narrative review of the literature." Scars, burns & healing 2017. PMID: 29799550 https://pubmed.ncbi.nlm.nih.gov/29799550/ [35] Shkrum MJ, Johnston KA. "Fire and suicide: a three-year study of self-immolation deaths." Journal of forensic sciences 1992. PMID: 1545201 https://pubmed.ncbi.nlm.nih.gov/1545201/ [36] Kales SN. "Carbon monoxide intoxication." American family physician 1993. PMID: 7694450 https://pubmed.ncbi.nlm.nih.gov/7694450/ [37] Borron SW, Baud FJ. "Antidotes for acute cyanide poisoning." Current pharmaceutical biotechnology 2012. PMID: 22352728 https://pubmed.ncbi.nlm.nih.gov/22352728/ [38] Alarie Y. "Toxicity of fire smoke." Critical reviews in toxicology 2002. PMID: 12184505 https://pubmed.ncbi.nlm.nih.gov/12184505/ [39] Hoffman RS, Sauter D. "Methemoglobinemia resulting from smoke inhalation." Veterinary and human toxicology 1989. PMID: 2648673 https://pubmed.ncbi.nlm.nih.gov/2648673/ [40] Harada K, et al.. "Analysis of cyanide exposure status in fire-related deaths using a physiologically based pharmacokinetic model." Forensic toxicology 2025. PMID: 39998734 https://pubmed.ncbi.nlm.nih.gov/39998734/ [41] Lee HM, Reed J, Greeley GH, Englander EW. "Impaired mitochondrial respiration and protein nitration in the rat hippocampus after acute inhalation of combustion smoke." Toxicology and applied pharmacology 2008. PMID: 19133281 https://pubmed.ncbi.nlm.nih.gov/19133281/ [42] Lawson-Smith P, Jansen EC, Hyldegaard O. "Cyanide intoxication as part of smoke inhalation--a review on diagnosis and treatment from the emergency perspective." Scandinavian journal of trauma, resuscitation and emergency medicine 2011. PMID: 21371322 https://pubmed.ncbi.nlm.nih.gov/21371322/ [43] Nicholson-Roberts TC. "Toxicology and military anaesthesia." Journal of the Royal Army Medical Corps 2010. PMID: 21302652 https://pubmed.ncbi.nlm.nih.gov/21302652/ [44] Westphal M, Morita N, Enkhbaatar P, Murakami K, Traber L, Traber DL. "Carboxyhemoglobin formation following smoke inhalation injury in sheep is interrelated with pulmonary shunt fraction." Biochemical and biophysical research communications 2003. PMID: 14623337 https://pubmed.ncbi.nlm.nih.gov/14623337/ [45] Borron SW, Baud FJ. "Acute cyanide poisoning: clinical spectrum, diagnosis, and treatment." Arhiv za higijenu rada i toksikologiju 1996. PMID: 8989894 https://pubmed.ncbi.nlm.nih.gov/8989894/ [46] Li SY, Petrikovics I, Yu J. "The potential use of 2-aminothiazoline-4-carboxylic acid (ATCA) as a forensic marker for cyanide exposure in medicolegal death investigation: A review." Forensic science review 2019. PMID: 30594906 https://pubmed.ncbi.nlm.nih.gov/30594906/ [47] Nishio T, Toukairin Y, Hoshi T, Arai T, Nogami M. "Quantification of cyanide metabolite 2-aminothiazoline-4-carboxylic acid in postmortem dried blood spot samples by liquid chromatography-tandem mass spectrometry." Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2023. PMID: 36580818 https://pubmed.ncbi.nlm.nih.gov/36580818/ [48] Anseeuw K, et al.. "Cyanide poisoning by fire smoke inhalation: a European expert consensus." European journal of emergency medicine : official journal of the European Society for Emergency Medicine 2013. PMID: 22828651 https://pubmed.ncbi.nlm.nih.gov/22828651/ [49] Weaver LK, Howe S, Hopkins R, Chan KJ. "Carboxyhemoglobin half-life in carbon monoxide-poisoned patients treated with 100% oxygen at atmospheric pressure." Chest 2000. PMID: 10713010 https://pubmed.ncbi.nlm.nih.gov/10713010/ [50] Weaver LK. "Carbon monoxide poisoning." Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc 2020. PMID: 32176957 https://pubmed.ncbi.nlm.nih.gov/32176957/ [51] Stanton EW, et al.. "Hydroxocobalamin is not associated with methemoglobinemia in patients with inhalation injury and suspected cyanide toxicity and a proposed algorithm for hydroxocobalamin administration." Burns : journal of the International Society for Burn Injuries 2024. PMID: 38760187 https://pubmed.ncbi.nlm.nih.gov/38760187/ [52] Dunne R, Goodloe JM, Augustine JJ, Begres T, Crowe RP, Carney E. "Intravenous Hydroxocobalamin for Cyanide Poisoning From Smoke Inhalation: A Comprehensive Scoping Review." Journal of the American College of Emergency Physicians open 2026. PMID: 41799837 https://pubmed.ncbi.nlm.nih.gov/41799837/ [53] Yan TT, Lin GA, Wang MJ, Lamkowski A, Port M, Rump A. "Pharmacological treatment of inhalation injury after nuclear or radiological incidents: The Chinese and German approach." Military Medical Research 2019. PMID: 30961671 https://pubmed.ncbi.nlm.nih.gov/30961671/ [54] Hall AH, Dart R, Bogdan G. "Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning?" Annals of emergency medicine 2007. PMID: 17098327 https://pubmed.ncbi.nlm.nih.gov/17098327/ [55] Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. "Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade." Clinical toxicology (Philadelphia, Pa.) 2006. PMID: 16990192 https://pubmed.ncbi.nlm.nih.gov/16990192/ [56] Kamta J, Maynard K, Schult RF, Bell DE, Jones CMC, Acquisto NM. "Evaluation of hydroxocobalamin use for the treatment of suspected cyanide toxicity secondary to smoke inhalation." Burns : journal of the International Society for Burn Injuries 2023. PMID: 37777459 https://pubmed.ncbi.nlm.nih.gov/37777459/ [57] Dumestre D, Nickerson D. "Use of cyanide antidotes in burn patients with suspected inhalation injuries in North America: a cross-sectional survey." Journal of burn care & research : official publication of the American Burn Association 2013. PMID: 23877146 https://pubmed.ncbi.nlm.nih.gov/23877146/ [58] Kaita Y, Tarui T, Shoji T, Miyauchi H, Yamaguchi Y. "Cyanide poisoning is a possible cause of cardiac arrest among fire victims, and empiric antidote treatment may improve outcomes." The American journal of emergency medicine 2018. PMID: 29395761 https://pubmed.ncbi.nlm.nih.gov/29395761/ [59] Jüttner B, et al.. "S2k guideline diagnosis and treatment of carbon monoxide poisoning." German medical science : GMS e-journal 2021. PMID: 34867135 https://pubmed.ncbi.nlm.nih.gov/34867135/ [60] Setia K, Newsom M, Hashimi H, Collins J, Senthil-Kumar P, Feldman MJ. "Carbon Monoxide-Related Vision Loss in an Acute Burn Patient." Journal of burn care & research : official publication of the American Burn Association 2024. PMID: 38833305 https://pubmed.ncbi.nlm.nih.gov/38833305/ [61] Al Khaldi T, Gulreez R, Abdelhamid MM, Louri N. "Acute carbon monoxide poisoning as a cause of rhabdomyolysis in a case of flame burn." BMJ case reports 2023. PMID: 37202107 https://pubmed.ncbi.nlm.nih.gov/37202107/ [62] Wang YM, et al.. "Exercise-induced myocardial ischemia presenting as exercise intolerance after carbon monoxide intoxication and smoke inhalation Injury: case report." BMC cardiovascular disorders 2022. PMID: 36575398 https://pubmed.ncbi.nlm.nih.gov/36575398/ [63] Ma KH, et al.. "Cyanide Poisoning Compromises Gene Pathways Modulating Cardiac Injury in Vivo." Chemical research in toxicology 2021. PMID: 33914522 https://pubmed.ncbi.nlm.nih.gov/33914522/ [64] Dhakal R, Zacharia GS, Javed N, K C P, Khaja M. "A Curious Case of Purple Chromaturia." Cureus 2025. PMID: 39925519 https://pubmed.ncbi.nlm.nih.gov/39925519/ [65] Dépret F, et al.. "Association between hydroxocobalamin administration and acute kidney injury after smoke inhalation: a multicenter retrospective study." Critical care (London, England) 2019. PMID: 31870461 https://pubmed.ncbi.nlm.nih.gov/31870461/ [66] Engwall AJ, Blache A, Lintner A, Bright A, Kahn S. "Hydroxocobalamin Administration After Inhalation Injury Is Not Associated With Mesenteric Ischemia." Annals of burns and fire disasters 2021. PMID: 34744539 https://pubmed.ncbi.nlm.nih.gov/34744539/ [67] Dang S, et al.. "Hydroxocobalamin interference in routine laboratory tests: Development of a protocol for identifying samples and reporting results from patients treated with CyanokitTM." Clinical biochemistry 2021. PMID: 33444605 https://pubmed.ncbi.nlm.nih.gov/33444605/ [68] Kiernan E, et al.. "Elevated Methemoglobin Levels in a Patient Treated with Hydroxocobalamin After Suspected Cyanide Exposure." The Journal of emergency medicine 2020. PMID: 33011041 https://pubmed.ncbi.nlm.nih.gov/33011041/ [69] Kiernan EA, et al.. "Elevated methemoglobin levels in patients treated with hydroxocobalamin: a case series and in-vitro analysis." Clinical toxicology (Philadelphia, Pa.) 2022. PMID: 35549585 https://pubmed.ncbi.nlm.nih.gov/35549585/ [70] Geller RJ, Barthold C, Saiers JA, Hall AH. "Pediatric cyanide poisoning: causes, manifestations, management, and unmet needs." Pediatrics 2006. PMID: 17079589 https://pubmed.ncbi.nlm.nih.gov/17079589/ [71] Mintegi S, et al.. "Pediatric cyanide poisoning by fire smoke inhalation: a European expert consensus. Toxicology Surveillance System of the Intoxications Working Group of the Spanish Society of Paediatric Emergencies." Pediatric emergency care 2013. PMID: 24196100 https://pubmed.ncbi.nlm.nih.gov/24196100/ [72] Conway K, Rayes O, Brown T, Webb M. "Atherosclerotic and Hypertensive Cardiovascular Disease are Associated with Death at Sublethal Carboxyhemoglobin Levels: A Postmortem Study." Journal of forensic sciences 2020. PMID: 31856351 https://pubmed.ncbi.nlm.nih.gov/31856351/ [73] Siddiqui Z, Ladha P, Dissanaike S. "Sickle Cell Disease, Severe Acidosis, and Inhalation Injury: Case Report of Neurologically Intact Survival After Cardiac Arrest From Smoke Inhalation." Journal of burn care & research : official publication of the American Burn Association 2016. PMID: 27984409 https://pubmed.ncbi.nlm.nih.gov/27984409/ [74] Fent KW, et al.. "Airborne contaminants during controlled residential fires." Journal of occupational and environmental hygiene 2018. PMID: 29494297 https://pubmed.ncbi.nlm.nih.gov/29494297/ [75] Sully CJ, Walker GS, Langlois NEI. "Review of autopsy reports of deaths relating to fire in South Australia 2000-2015." Forensic science, medicine, and pathology 2018. PMID: 29705973 https://pubmed.ncbi.nlm.nih.gov/29705973/ [76] Şahin HÇ, et al.. "Fire covering the murder: diagnostic challenges of postmortem burning in carbonized victims." Irish journal of medical science 2025. PMID: 41082061 https://pubmed.ncbi.nlm.nih.gov/41082061/ [77] Crewe RJ, Andrews SP, Hull TR, Birbeck PN, Stec AA. "Combustion and toxic gas production from disposable barbecues in enclosures." Journal of forensic sciences 2014. PMID: 24117527 https://pubmed.ncbi.nlm.nih.gov/24117527/ [78] Clark RJ, Beeley JM. "Smoke inhalation." British journal of hospital medicine 1989. PMID: 2653542 https://pubmed.ncbi.nlm.nih.gov/2653542/ [79] Peters WJ. "Inhalation injury caused by the products of combustion." Canadian Medical Association journal 1981. PMID: 7023640 https://pubmed.ncbi.nlm.nih.gov/7023640/ [80] Thaler U, Kraincuk P, Kamolz LP, Frey M, Metnitz PG. "[Inhalation injury--epidemiology, diagnosis and therapy]." Wiener klinische Wochenschrift 2010. PMID: 20177854 https://pubmed.ncbi.nlm.nih.gov/20177854/ [81] Haden M, et al.. "Potential cyanide poisoning reported to the UK national poisons information service: 2008-2019." Clinical toxicology (Philadelphia, Pa.) 2022. PMID: 35635241 https://pubmed.ncbi.nlm.nih.gov/35635241/ [82] [No authors listed]. "Cyanide toxicity. Agency for Toxic Substances and Disease Registry." American family physician 1993. PMID: 8322636 https://pubmed.ncbi.nlm.nih.gov/8322636/ [83] Vural T, Erbaş M, Ketenci HÇ. "A forensic disciplinary investigation of deaths caused by traditional wooden house fires; A 10-year autopsy study in Turkey." Medicine, science, and the law 2026. PMID: 41877643 https://pubmed.ncbi.nlm.nih.gov/41877643/ [84] Nguyen L, Afshari A, Kahn SA, McGrane S, Summitt B. "Utility and outcomes of hydroxocobalamin use in smoke inhalation patients." Burns : journal of the International Society for Burn Injuries 2016. PMID: 27554631 https://pubmed.ncbi.nlm.nih.gov/27554631/ [85] Wong E, Dodson N, Wagner S, Thornton S. "Time to Burn? Characteristics of Hydroxocobalamin Administration in an Academic Medical Center." Journal of pharmacy practice 2024. PMID: 36318086 https://pubmed.ncbi.nlm.nih.gov/36318086/ [86] Raška F, Lipový B, Hladík M, Holoubek J. "Cyanide poisoning in patients with inhalation injury - the phantom menace." Acta chirurgiae plasticae 2021. PMID: 35042362 https://pubmed.ncbi.nlm.nih.gov/35042362/ [87] Cumpston KL, et al.. "Evaluation of prehospital hydroxocobalamin use in the setting of smoke inhalation." The American journal of emergency medicine 2021. PMID: 34461397 https://pubmed.ncbi.nlm.nih.gov/34461397/ [88] Thompson JP, Marrs TC. "Hydroxocobalamin in cyanide poisoning." Clinical toxicology (Philadelphia, Pa.) 2012. PMID: 23163594 https://pubmed.ncbi.nlm.nih.gov/23163594/ [89] Alyafi T, Al-Marzouki AH, Al Hassani AN. "Therapeutic Outcome of Burn Patients Treated With Hyperbaric Oxygen." Cureus 2021. PMID: 34786252 https://pubmed.ncbi.nlm.nih.gov/34786252/ [90] Weitgasser L, Ihra G, Schäfer B, Markstaller K, Radtke C. "Update on hyperbaric oxygen therapy in burn treatment." Wiener klinische Wochenschrift 2021. PMID: 31701218 https://pubmed.ncbi.nlm.nih.gov/31701218/ [91] Simonsen C, Thorsteinsson K, Mortensen RN, Torp-Pedersen C, Kjærgaard B, Andreasen JJ. "Carbon monoxide poisoning in Denmark with focus on mortality and factors contributing to mortality." PloS one 2019. PMID: 30653615 https://pubmed.ncbi.nlm.nih.gov/30653615/ [92] Hill IR. "Incapacitation and fires." The American journal of forensic medicine and pathology 1989. PMID: 2648811 https://pubmed.ncbi.nlm.nih.gov/2648811/ [93] Morningstar J, et al.. "Intramuscular administration of hexachloroplatinate reverses cyanide-induced metabolic derangements and counteracts severe cyanide poisoning." FASEB bioAdvances 2019. PMID: 31355359 https://pubmed.ncbi.nlm.nih.gov/31355359/